Growth Metrics

Gilead Sciences (GILD) Operating Margin (QoQ) (2009 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 1,212.00
Dec 31, 2025 -1,779.00
Sep 30, 2025 789.00
Jun 30, 2025 138.00
Mar 31, 2025 116.00
Dec 31, 2024 2,063.00
Sep 30, 2024 -2,625.00
Jun 30, 2024 10,266.00
Mar 31, 2024 -8,730.00
Dec 31, 2023 -1,454.00
Sep 30, 2023 1,197.00
Jun 30, 2023 -161.00
Mar 31, 2023 -384.00
Dec 31, 2022 -961.00
Sep 30, 2022 787.00
Jun 30, 2022 2,942.00
Mar 31, 2022 -999.00
Dec 31, 2021 -3,880.00
Sep 30, 2021 1,565.00
Jun 30, 2021 -887.00
Mar 31, 2021 927.00
Dec 31, 2020 530.00
Sep 30, 2020 8,843.00
Jun 30, 2020 -10,130.00
Mar 31, 2020 2,470.00
Dec 31, 2019 4,488.00
Sep 30, 2019 -6,903.00
Jun 30, 2019 38.00
Mar 31, 2019 2,262.00
Dec 31, 2018 -2,713.00
Sep 30, 2018 650.00
Jun 30, 2018 -195.00
Mar 31, 2018 3,097.00
Dec 31, 2017 -4,719.00
Sep 30, 2017 -103.00
Jun 30, 2017 166.00
Mar 31, 2017 265.00
Dec 31, 2016 -339.00
Sep 30, 2016 29.00
Jun 30, 2016 -132.00
Mar 31, 2016 -641.00
Dec 31, 2015 -125.00
Sep 30, 2015 -79.00
Jun 30, 2015 -260.00
Mar 31, 2015 1,153.00
Dec 31, 2014 160.00
Sep 30, 2014 -992.00
Jun 30, 2014 664.00
Mar 31, 2014 2,251.00
Dec 31, 2013 -288.00
Sep 30, 2013 -45.00
Jun 30, 2013 121.00
Mar 31, 2013 -227.00
Dec 31, 2012 -26.00
Sep 30, 2012 -101.00
Jun 30, 2012 898.00
Mar 31, 2012 -437.00
Dec 31, 2011 -788.00
Sep 30, 2011 -26.00
Jun 30, 2011 74.00
Mar 31, 2011 533.00
Dec 31, 2010 -903.00
Sep 30, 2010 -98.00
Jun 30, 2010 -416.00
Mar 31, 2010 324.00
Dec 31, 2009 277.00
Sep 30, 2009 345.00
Jun 30, 2009 -661.00